help button home button The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 9, No. 5, 550-555, September 2004; doi:10.1634/theoncologist.9-5-550
© 2004 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Superior Sulcus Tumors: A Mini-Review
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Archie, V. C.
Right arrow Articles by Thomas, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Archie, V. C.
Right arrow Articles by Thomas, C. R., Jr.

Superior Sulcus Tumors: A Mini-Review

Victor C. Archiea, Charles R. Thomas, Jr.b

a Department of Radiation Oncology, UCLA Jonsson Cancer Center, Los Angeles, California, USA; b Department of Radiation Oncology and Division of Medical Oncology/Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio Cancer Institute, San Antonio, Texas, USA

Charles R. Thomas Jr., M.D., Department of Radiation Oncology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, Texas 78229, USA. Telephone: 210-616-5684; Fax: 210-949-5085; e-mail: cthomas{at}ctrc.net; Website: http://www.uthscsa.edu/radiationoncology

The management and outcome for superior sulcus tumors have remained unchanged for 40 years. The rarity of these tumors has led to varying treatment techniques spanning decades, from which no solid conclusions can be drawn. Recent advances in combined-modality therapy have offered the first inkling that a paradigm shift is on the horizon. Here, we review the history and new advances in treating this challenging pulmonary neoplasm.

Key Words. Pancoast • Superior sulcus • Non-small cell lung cancer • Combined-modality






HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl

Copyright © 2004 by AlphaMed Press.